WHO Approves First Mpox Vaccine for Prequalification, MVA-BN

Brief by Shorts91 Newsdesk / 02:57pm on 13 Sep 2024,Friday Health & Wellness

The World Health Organization (WHO) has prequalified the MVA-BN vaccine as the first mpox vaccine, enhancing access to vital immunization against the disease. Approved for individuals over 18, the vaccine is administered in two doses, four weeks apart. It can be stored at 2-8°C for up to eight weeks. The WHO emphasizes urgent procurement and distribution to tackle ongoing outbreaks, particularly in Africa. While the vaccine is not licensed for those under 18, it may be used "off-label" in high-risk outbreak settings. Data shows the vaccine's effectiveness at 76% for single-dose and 82% for the two-dose regimen.

Read More at NDTV

India Reports First Confirmed Case of Monkeypox, Government Says Situation Under Control

Brief by Shorts91 Newsdesk / 10:21am on 11 Sep 2024,Wednesday Health & Wellness

India reports its first confirmed case of Monkeypox, a travel-related infection, in a patient who was isolated with symptoms. The central government assures that the situation is under control and being handled according to established protocols. Public health measures, including contact tracing and monitoring, are in place to prevent further spread. The case is not part of the current public health emergency related to the 'clade 1' strain of Mpox. No broader risk to the public has been detected, and the government is closely monitoring the situation. The patient's identity and travel history have not been disclosed.

Read More at The Times Of India

India Reports First Mpox Case: Isolated Patient with Travel History Tests Positive

Brief by Shorts91 Newsdesk / 03:33pm on 10 Sep 2024,Tuesday Health & Wellness

India has reported its first Mpox case, with the infected individual confirmed to have contracted the West African clade 2 virus. The patient, who traveled from a country experiencing an Mpox outbreak, showed symptoms upon return and has since been isolated. Authorities have initiated contact tracing and are managing the case according to established protocols. Although Mpox, particularly the new Clade 1b variant in the Democratic Republic of Congo, is causing international concern, this isolated case is not part of the current public health emergency. The patient is stable and poses no immediate risk to the public.

Read More at News18

India Detects First Suspected Mpox Case Amid WHO Health Emergency

Brief by Shorts91 Newsdesk / 06:34pm on 08 Sep 2024,Sunday Health & Wellness

India has identified its first suspected case of mpox, previously known as monkeypox, following the World Health Organisation’s declaration of a Public Health Emergency of International Concern last month. The patient, a young male who recently traveled from a country with active mpox transmission, is currently isolated, and his sample is being tested. The Health Ministry reassured that the risk of a large outbreak in India remains low. Measures, including alerts at entry points and readiness of laboratories, were implemented following the WHO alert. Mpox, caused by the MPXV virus, can lead to severe symptoms, especially in vulnerable populations.

Read More at The Indian Express

India Reports First Suspected Mpox Case, Government Assures No Cause for Alarm

Brief by Shorts91 Newsdesk / 12:24pm on 08 Sep 2024,Sunday Health & Wellness

India has reported its first suspected Mpox case, with a young man recently returned from a country experiencing an outbreak. The patient, in stable condition, is undergoing isolation and testing to confirm the infection. Authorities have initiated contact tracing to assess potential risks. The National Centre for Disease Control (NCDC) emphasizes that there is no cause for alarm, stating that measures are in place to manage and mitigate the situation. Mpox, formerly known as monkeypox, is spread through close contact and is currently a concern in several countries, including the DRC.

Read More at News18

Congo Receives First Batch of Mpox Vaccines as Outbreak Worsens

Brief by Shorts91 Newsdesk / 05:17pm on 05 Sep 2024,Thursday Health & Wellness

The Democratic Republic of Congo received its first shipment of 99,000 mpox vaccine doses on September 5, 2024. The vaccines, manufactured by Bavarian Nordic and donated by the EU, arrived in Kinshasa and are aimed at combating a severe outbreak that led the U.N. to declare a global health emergency. Health Minister Samuel Roger Kamba Mulamba announced plans to target high-affected areas such as Equateur and South Kivu. A second delivery on September 7 will bring the total to 200,000 doses. Congo’s vaccination campaign is set to start on October 8.

Read More at NDTV

'I'm Getting a New Heart': Six-Year-Old Joyfully Announces Life-Saving Heart Transplant

Brief by Shorts91 Newsdesk / 11:58am on 29 Aug 2024,Thursday Health & Wellness

Six-year-old John-Henry from the United States, born with a rare heart defect known as hypoplastic left heart syndrome (HLHS), joyfully announced he was getting a new heart after waiting six months for a transplant. The Cleveland Clinic Children's Hospital patient shared the happy news with staff, saying, "I'm getting a new heart!" John-Henry had undergone multiple surgeries due to his condition, but a heart transplant became his only option. In May 2024, after being placed on the transplant list in December 2023, a donor match was found. John-Henry’s transplant was successful, and he was released from the hospital on August 23.

Read More at Sky News

New COVID Vaccine Released, but Experts Say Some May Want to Wait

Brief by Shorts91 Newsdesk / 04:42pm on 27 Aug 2024,Tuesday Health & Wellness

The FDA has approved a new COVID-19 vaccine for everyone aged 6 months and up. However, experts suggest that healthy individuals who have already been vaccinated or previously infected may want to wait before getting the shot. Immunity from previous vaccines and infections could still offer protection. Those at high risk, like older adults or those with chronic conditions, are encouraged to get the vaccine sooner. The new vaccine targets a recent Omicron variant, but concerns about its effectiveness against future variants remain.

Read More at ABC News

Odisha on High Alert as Bird Flu Spreads, 20,000 Chickens Culled in Puri District

Brief by Shorts91 Newsdesk / 03:22am on 27 Aug 2024,Tuesday Health & Wellness

Avian Influenza (Bird Flu) has been detected in Odisha’s Puri district, leading to the culling of approximately 20,000 chickens in the Pipli and Satyabadi areas over the past three days. The state's health department has ordered increased surveillance to protect human health, emphasizing the virus can spread from infected birds to humans through inhalation, though there's no confirmed human-to-human transmission. Director of Public Health, Nilakantha Mishra, directed Puri’s chief district medical officer to closely coordinate with other departments to monitor any unexplained bird deaths. The culling was initiated after reports of chicken deaths at a poultry farm in Pipli emerged, with 13 state government teams involved in the operation.

Read More at The Indian Express

How India Can Stay Safe From Monkeypox: Symptoms and Steps to Follow as Virus Spreads Globally

Brief by Shorts91 Newsdesk / 07:26pm on 22 Aug 2024,Thursday Health & Wellness

Monkeypox is spreading globally, and India's concern grows as the virus reaches Pakistan. Originating in Africa, it has now been declared a public health emergency by the World Health Organization. Dr. Baset Hakim from Apollo Clinic outlines key safety measures for India: monitor symptoms like fever, rashes, and exhaustion, and take swift action. Transmission occurs through respiratory droplets or direct contact with fluids. To stay safe, isolation of infected individuals, covering lesions, and wearing masks are crucial. India must act quickly, as children are particularly vulnerable to severe cases.

Read More at Zee News

Menu